Oaktop Capital Management II’s Bristol-Myers Squibb BMY Stock Holding History

Oaktop Capital Management II’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27.7M	Hold	479,991	–	–	1.18%	7
2026 Q1	$29.1M	Hold	479,991	–	–	2.17%	5
2025 Q4	$25.9M	Hold	479,991	–	–	2.19%	6
2025 Q3	$21.6M	Hold	479,991	–	–	1.96%	8
2025 Q2	$22.2M	Hold	479,991	–	–	2.39%	7
2025 Q1	$29.3M	Hold	479,991	–	–	3.9%	5
2024 Q4	$27.1M	Hold	479,991	–	–	3.39%	7
2024 Q3	$24.8M	Sell	479,991 -200,000	-29%	-$9.38M	2.71%	7
2024 Q2	$28.2M	Hold	679,991	–	–	2.89%	6
2024 Q1	$36.9M	Hold	679,991	–	–	4.26%	6
2023 Q4	$34.9M	Hold	679,991	–	–	4.63%	6
2023 Q3	$39.5M	Hold	679,991	–	–	6.59%	4
2023 Q2	$43.5M	Hold	679,991	–	–	6.61%	4
2023 Q1	$47.1M	Hold	679,991	–	–	7.92%	4
2022 Q4	$48.9M	Hold	679,991	–	–	8.76%	4
2022 Q3	$48.3M	Hold	679,991	–	–	9.72%	4
2022 Q2	$52.4M	Hold	679,991	–	–	9.48%	4
2022 Q1	$49.7M	Hold	679,991	–	–	7.09%	5
2021 Q4	$42.4M	Hold	679,991	–	–	5.11%	5
2021 Q3	$40.2M	Hold	679,991	–	–	5.57%	5
2021 Q2	$45.4M	Hold	679,991	–	–	6.5%	5
2021 Q1	$42.9M	Hold	679,991	–	–	6.62%	5
2020 Q4	$42.2M	Hold	679,991	–	–	7.43%	5
2020 Q3	$41M	Hold	679,991	–	–	9.06%	4
2020 Q2	$40M	Hold	679,991	–	–	9.4%	4
2020 Q1	$37.9M	Buy	679,991 +125,000	+23%	+$7.64M	11.6%	3
2019 Q4	$35.6M	Buy	+554,991	New	+$31.8M	9.35%	4

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Oaktop Capital Management II's BMY Position: Q2 2026 in Review

Oaktop Capital Management II held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 479,991 shares worth $27.7M. The position accounts for 1.18% of the portfolio, ranked #7.

Oaktop Capital Management II first reported a position in BMY in Q4 2019 and has held it in 27 quarters since. The position peaked at $52.4M in Q2 2022. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Oaktop Capital Management II held 479,991 shares of Bristol-Myers Squibb worth $27.7M as of Q2 2026.
Oaktop Capital Management II left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 1.18% of Oaktop Capital Management II's portfolio in Q2 2026, its #7 holding.
Oaktop Capital Management II first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 27 quarters since.
Oaktop Capital Management II's Bristol-Myers Squibb position peaked at $52.4M in Q2 2022.
2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Oaktop Capital Management II's 13F filing for Q2 2026, filed 7 Aug 2026.